Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Finco-Kent

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunotoxicology|October 30, 2008
Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluationDeborah Finco-Kent, Thomas T Kawabata
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trialS Edwin Fineberg, Tom Kawabata, Deborah Finco-Kent, et al.
Journal of Immunotoxicology|October 30, 2008
Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893Daniel J Baltrukonis, Deborah Finco-Kent, Thomas T Kawabata, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Development and validation of radioligand binding assays to measure total, IgA, IgE, IgG, and IgM insulin antibodies in human serumMichaeI Moxness, Jim Foley, Mark Stene, et al.
Diabetes Care|August 27, 2005
The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic studyTim Heise, Susanne Bott, Corinna Tusek, et al.
Endocrine Reviews|September 6, 2007
Immunological responses to exogenous insulinS Edwin Fineberg, Thomas T Kawabata, Deborah Finco-Kent, et al.
Journal of Medicinal Chemistry|March 19, 2010
Synthesis and characterization of rhenium and technetium-99m labeled insulinChitra Sundararajan, Travis R Besanger, Renee Labiris, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Science (New York, N.Y.)|November 1, 2003
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitorPaul S Changelian, Mark E Flanagan, Douglas J Ball, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunotoxicology|October 30, 2008
Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluationDeborah Finco-Kent, Thomas T Kawabata
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trialS Edwin Fineberg, Tom Kawabata, Deborah Finco-Kent, et al.
Journal of Immunotoxicology|October 30, 2008
Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893Daniel J Baltrukonis, Deborah Finco-Kent, Thomas T Kawabata, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Development and validation of radioligand binding assays to measure total, IgA, IgE, IgG, and IgM insulin antibodies in human serumMichaeI Moxness, Jim Foley, Mark Stene, et al.
Diabetes Care|August 27, 2005
The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic studyTim Heise, Susanne Bott, Corinna Tusek, et al.
Endocrine Reviews|September 6, 2007
Immunological responses to exogenous insulinS Edwin Fineberg, Thomas T Kawabata, Deborah Finco-Kent, et al.
Journal of Medicinal Chemistry|March 19, 2010
Synthesis and characterization of rhenium and technetium-99m labeled insulinChitra Sundararajan, Travis R Besanger, Renee Labiris, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Science (New York, N.Y.)|November 1, 2003
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitorPaul S Changelian, Mark E Flanagan, Douglas J Ball, et al.
Pageof 1